Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD
Rafael Paternostro, Wilhelmus J. Kwanten, Benedikt Hofer, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 5, pp. 827-836
Open Access | Times Cited: 12

Showing 12 citing articles:

Severe alpha-1 antitrypsin deficiency shows a higher risk of complications after first decompensation compared to other aetiologies of cirrhosis☆
Lorenz Balcar, Malin Fromme, Naomi Kappe, et al.
JHEP Reports (2025), pp. 101398-101398
Open Access
Correspondence on “Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD” - Authors' Reply
Benedikt Hofer, Wilhelmus J. Kwanten, Sven Francque
Journal of Hepatology (2025)
Closed Access
EASL-Post-Graduate course Report: Vascular Biology in Chronic Liver Disease and Clinical Management Implications☆
Pierre‐Emmanuel Rautou, Ton Lisman, Virginia Hernández‐Gea, et al.
JHEP Reports (2025), pp. 101399-101399
Open Access
Author's Reply: “Comment on: Aetiology-specific inflammation patterns in patients and rat models of compensated cirrhosis”
Benedikt Hofer, Thomas Reiberger
Digestive and Liver Disease (2025)
Closed Access
Recompensation in Cirrhosis: Biomarkers and Strategies
Wagner Ramírez-Quesada, Edilmar Alvarado‐Tápias, Sarah Shalaby, et al.
Seminars in Liver Disease (2025)
Closed Access
MetALD accounts for a large part of what we call MASLD!
Marika Rudler, Charlotte Bouzbib, Dominique Thabut
Journal of Hepatology (2024) Vol. 81, Iss. 6, pp. e283-e284
Closed Access | Times Cited: 2
Clinically significant portal hypertension in patients with primary biliary cholangitis: Clinicopathological features and prognostic value
Ying Zhang, Huaying Lai, Jing Chen, et al.
Annals of Hepatology (2024), pp. 101577-101577
Open Access | Times Cited: 2
Endoscopic Bariatric and Metabolic Therapies and Its Effect on MASLD: A Review of the Current Literature
Varun Aitharaju, Jonathan Ragheb, Stephen A. Firkins, et al.
Surgery for Obesity and Related Diseases (2024)
Closed Access | Times Cited: 1
Editorial: Tracking the course of Wilson's disease: Authors' reply
Lukas Burghart, Thomas Reiberger, A.F. Staettermayer
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 6, pp. 813-814
Closed Access
Reply to “MetALD accounts for a large part of what we call MASLD!”
Wilhelmus J. Kwanten, Benedikt Hofer, Sven Francque
Journal of Hepatology (2024) Vol. 81, Iss. 6, pp. e285-e286
Closed Access
Correspondence on “Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD”
Yijia Guan, Qiongguang Huang
Journal of Hepatology (2024)
Closed Access
Transjugular Intrahepatic Portosystemic Shunt (TIPS): A Bridge to Bariatric Surgery in Morbidly Obese Patients with Cirrhosis and Clinically Significant Portal Hypertension
Raluca Pais, Yasmina Chouik, Lucile Moga, et al.
Obesity Surgery (2024)
Closed Access
Page 1

Scroll to top